Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract ...

FDA Recall #D-1139-2023 — Class III — August 23, 2023

Recall #D-1139-2023 Date: August 23, 2023 Classification: Class III Status: Terminated

Product Description

Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC# 71428-003-60

Reason for Recall

Defective Container: slow leakage under the cap

Recalling Firm

Contract Pharmaceuticals Limited Canada — Mississauga, N/A

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

11,350 bottles

Distribution

Nationwide in the USA.

Code Information

Lot # 118920, exp. January 2024.

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated